Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Leucovorin × Clear all

Sponsor

Conditions

Colorectal Neoplasms 86 Rectal Neoplasms 40 Colonic Neoplasms 35 Pancreatic Neoplasms 31 Stomach Neoplasms 28 Neoplasm Metastasis 22 Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Esophageal Neoplasms 18 Adenocarcinoma Of Esophagus 13 Lymphoma 11 Burkitt Lymphoma 11 Leukemia 6 Adenocarcinoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Osteosarcoma 4 Lymphoma, Mantle-Cell 4 Gastrointestinal Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lymphoma, Non-Hodgkin 3 Liver Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Intestinal Neoplasms 3 Gallbladder Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Somatostatinoma 2 Metastatic Pancreatic Adenocarcinoma 2 Lung Neoplasms 2

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡